Filtros de búsqueda

Lista de obras de Carsten Niemann

Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival

artículo científico publicado en 2020

Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study

artículo científico publicado en 2020

B-cell receptor signaling as a driver of lymphoma development and evolution

artículo científico publicado en 2013

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

scientific article published on 29 June 2020

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

artículo científico publicado en 2021

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

artículo científico publicado en 2020

Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib

artículo científico publicado en 2020

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

artículo científico publicado en 2017

Clinical Outcomes in Patients with Multi-Hit <i>TP53</i> Chronic Lymphocytic Leukemia Treated with Ibrutinib

publication published on 07 May 2021

Cocreated Smartphone App to Improve the Quality of Life of Adolescents and Young Adults with Cancer (Kræftværket): Protocol for a Quantitative and Qualitative Evaluation.

artículo científico publicado en 2018

Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model.

artículo científico publicado en 2017

Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

scientific article published on 24 September 2020

Correction: Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study

artículo científico publicado en 2020

Cost-effectiveness targeting CLL

artículo científico publicado en 2020

Deep targeted sequencing of in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment

artículo científico publicado en 2018

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase II study.

artículo científico publicado en 2018

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

scientific article published on 21 December 2020

Developing Age-Appropriate Supportive Facilities, Resources, and Activities for Adolescents and Young Adults with Cancer Across Departments and Diagnoses: A Single-Center Experience

artículo científico publicado en 2018

Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study

artículo científico publicado en 2020

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

artículo científico publicado en 2016

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood

artículo científico publicado en 2017

Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study

artículo científico publicado en 2015

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

artículo científico publicado en 2019

Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

artículo científico publicado en 2022

Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study

artículo científico publicado en 2018

Expression analyses of human cleft palate tissue suggest a role for osteopontin and immune related factors in palatal development

artículo científico publicado en 2009

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

artículo científico publicado en 2020

Highly glycosylated alpha1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophils

artículo científico publicado en 2005

Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death

artículo científico publicado en 2016

IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study

scientific article published on 03 October 2019

Ibrutinib and Venetoclax for First-Line Treatment of CLL

artículo científico publicado en 2019

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

artículo científico publicado en 2014

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

artículo científico publicado en 2018

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

artículo científico publicado en 2014

Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark.

artículo científico publicado en 2018

Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients

artículo científico publicado en 2016

Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study

artículo científico publicado en 2018

Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

artículo científico publicado en 2015

Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy.

artículo científico publicado en 2015

Localization of serglycin in human neutrophil granulocytes and their precursors

artículo científico publicado en 2004

Machine learning can identify newly diagnosed patients with CLL at high risk of infection

scientific article published on 17 January 2020

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

artículo científico publicado en 2016

Multi-facetted clinical presentation of thrombotic thrombocytopenic purpura

artículo científico publicado en 2009

Neutrophil elastase depends on serglycin proteoglycan for localization in granules

artículo científico publicado en 2007

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

artículo científico publicado en 2017

On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response

artículo científico publicado en 2005

Pain characteristics and management of inpatients admitted to a comprehensive cancer centre: a cross-sectional study

artículo científico publicado en 2013

Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy

scientific article published on 23 July 2020

Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning

artículo científico publicado en 2022

Positive results with haematology webcasting for junior doctors

artículo científico publicado en 2016

Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR

scientific article published on 15 October 2020

Quality of life and symptoms in patients with malignant diseases admitted to a comprehensive cancer centre.

artículo científico publicado en 2014

Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients Admitted to Hospital With Coronavirus Disease 2019 (COVID-19)

artículo científico publicado en 2022

Real-World Outcomes for 205 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

artículo científico publicado en 2020

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

artículo científico publicado en 2018

Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study

artículo científico publicado en 2020

Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia

artículo científico publicado en 2007

Serglycin proteoglycan is not implicated in localizing exocrine pancreas enzymes to zymogen granules.

artículo científico publicado en 2009

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.

artículo científico publicado en 2017

Suspected Richter transformation: positron emission tomography/computed tomography tells us who should have a biopsy and where.

artículo científico publicado en 2013

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

artículo científico publicado en 2017

Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies

scientific article published on 01 November 2018

The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia

artículo científico publicado en 2016

The CLL-IPI applied in a population-based cohort

artículo científico publicado en 2016

The Danish National Chronic Lymphocytic Leukemia Registry

artículo científico publicado en 2016

The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome

artículo científico publicado en 2020

Towards targeted therapy of chronic lymphocytic leukemia

artículo científico publicado en 2013

Using Cocreation in the Process of Designing a Smartphone App for Adolescents and Young Adults With Cancer: Prototype Development Study

scientific article published on 01 November 2018

Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

scientific article published on 07 October 2020

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

artículo científico publicado en 2019

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2020

Washington DC vs. Copenhagen

artículo científico publicado en 2013

[In Process Citation]

[Targeted treatment of chronic lymphocytic leukaemia].

artículo científico publicado en 2014